Serina Therapeutics(DE:2BO)
€1.31+0.00 (+3.97%)
DE:2BO
Serina Therapeutics earnings date
€1.31
At close:+0.00 (+3.97%)
Serina Therapeutics (2BO) Q3 2026 Earnings Report
1 Followers
DE:2BO Q3 2026 EPS Results
- Actual EPS
- -EUR 0.28
- Consensus EPS
- -EUR 0.31
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- -EUR 0.41
DE:2BO Q3 2026 Revenue Results
- Actual Revenue
- EUR 113.39K
- Expected Revenue
- EUR 0
- Beat/Miss
- Beat by +EUR 113.39K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2026
- Date
- 11/12/2026
- Time
- After Close
- Conference Call
- Thursday, November 12, 2026
DE:2BO Upcoming Earnings
Serina Therapeutics's next earnings date is estimated for March 30, 2027, based on past reporting schedules.
Q3 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2BO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 30, 2027 | 2026 (Q4) | -0.27- | -0.28 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.31-0.28 | -0.41 | 31.11% (+0.13) | |
| Aug 13, 2026 | 2026 (Q2) | -0.42-0.50 | -0.6 | 16.67% (+0.10) | |
| May 14, 2026 | 2026 (Q1) | -0.40-0.53 | -0.44 | -18.37% (-0.08) | |
| Mar 25, 2026 | 2025 (Q4) | -0.45-0.28 | -1.03 | 72.57% (+0.74) | |
| Nov 13, 2025 | 2025 (Q3) | -0.48-0.41 | 0.12 | -443.51% (-0.53) | |
| Aug 11, 2025 | 2025 (Q2) | -0.39-0.60 | 0.46 | -228.91% (-1.06) | |
| May 08, 2025 | 2025 (Q1) | -0.56-0.44 | -3.07 | 85.51% (+2.62) | |
| Mar 24, 2025 | 2024 (Q4) | 0.38-1.03 | -2.91 | 64.72% (+1.88) | |
| Nov 12, 2024 | 2024 (Q3) | ―0.12 | -4.54 | 102.62% (+4.66) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
